本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

10.36
-0.2450-2.31%
成交量:88.67万
成交额:924.91万
市值:9.19亿
市盈率:-3.08
高:10.68
开:10.60
低:10.31
收:10.60
52周最高:13.90
52周最低:7.36
股本:8,877.44万
流通股本:7,060.22万
量比:0.69
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
净资产收益率:-167.71%
总资产收益率:-31.30%
市净率:18.98
市盈率(LYR):-3.26

数据加载中...

2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/10/24

重要事件披露

Form 8-K - Current report
2025/10/16

重要事件披露

Form 8-K - Current report
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]